We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Plans to Open Patient-Level Trial Data to Outside Researchers
GSK Plans to Open Patient-Level Trial Data to Outside Researchers
October 24, 2012
GlaxoSmithKline will soon give researchers access to detailed anonymized patient-level clinical data for approved drugs and dropped investigational products.